SOURCE: SkyePharma PLC

September 07, 2007 04:00 ET

SkyePharma PLC announces Appointment of Advisor

London, UK--(Marketwire - September 7, 2007) -

                                 SkyePharma PLC

                             Appointment of Adviser

LONDON, UK, 7 September 2007 - SkyePharma PLC (LSE: SKP) announces the appointment of Piper Jaffray Ltd. as its joint broker and joint financial adviser, to work alongside its existing broker and financial adviser, Credit Suisse Securities (Europe) Limited, with immediate effect.

For further information please contact:

SkyePharma PLC                      Frank Condella        +44 20 7491 1777
                                    Ken Cunningham
                                    Peter Grant

Financial Dynamics (UK Enquiries)   David Yates           +44 20 7831 3113
                                    Deborah Scott

Trout Group (US Enquiries)          Christine Labaree     +1 617 583 1308
                                    Seth Lewis

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life- cycle extension. The Company has eleven approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies.

For more information, visit

                      This information is provided by RNS
            The company news service from the London Stock Exchange